Qured and Epassi UK: expanding our reach

Epassi UK partners with Qured to unlock employee access to preventative health screenings and care

Leading provider of employee benefits technology, Epassi UK, has partnered with preventative health screening service, Qured, offering remote, pain-free blood tests, onward referrals to NHS or private providers, and personalised health plans for employees to follow.
Sickness in the UK workforce costs businesses around £100 billion, highlighting a clear need to support the wider healthcare system, improve employee health, and reduce risks for employers.
The partnership will extend Epassi UK’s health and wellbeing offering, reducing costs for businesses and supporting workers’ health.

London, UK, 6 November 2025: Leading provider of employee benefits technology, Epassi UK, has partnered with Qured, a preventative health intelligence partner providing a range of at home health screenings and pain-free* blood tests to businesses and their employees.

Via an easy-to-use app, Qured offers an array of personalised health services and pain-free blood collection. Its at-home screenings are as comprehensive as in-clinic yet reduce the cost for businesses and employees. This service provides a detailed health profile, a clinical results review, and a video consultation as standard for any abnormal results.

Currently, sickness in the UK workforce costs businesses around £100 billion, and around two thirds of workers lack access to health screenings.** There’s a clear need to tackle this crisis. Placing greater focus on preventative health services can better support employee’s wellbeing, the UK’s struggling healthcare system, and reduce the risk for businesses – all of which will help the wider economy by boosting productivity.

In addition to pain-free at home blood collection, all Qured packages include optional live video-guided support, rapid results in 48-72 hours, and a detailed personalised care plan from a Qured GP. The combined solution helps both identify immediate health concerns and deliver behaviour change, with 80% of users making lifestyle changes after completing their test, transforming the health of businesses’ workforces across the UK and Europe.

Matt Russell, CEO of Zest and Epassi UK said; “Excellent health and wellbeing benefits are vital in modern workplaces. Preventative screenings and at home blood tests, such as those Qured offers, will be transformative, contributing to Epassi UK’s wider mission of boosting the wellbeing of workers. Not only will this partnership support employees, helping them to keep fit and well, but it will also benefit businesses, lowering insurance costs, encouraging better performance, and improving workplace culture.”

When asked to create their own benefits package, 21% of employees stated they’d like a wellbeing allowance to spend on what they’d like.***. Epassi’s partnership with Qured will enhance its health and wellbeing services, delivering reduced health risks and costs to 50,000 employers, and an improved health offering to more than 36 million employees.

84% of employees who use Qured stick with their personalised plan, and by year two, 91% have at least five healthier biomarkers. Businesses also report a 20% reduction in sickness absence , marking significant cost savings through improved employee retention and reduced insurance premiums.

Alex Templeton, CEO and Co-Founder of Qured said: “There’s heightened demand for affordable and convenient healthcare services which work around people’s lives. Qured makes accessing preventative healthcare easier, quicker and more affordable. Our proactive approach reduces costs for employers and improves the health of employees – before they go off sick. Partnering with Epassi UK will allow us to extend this offered to thousands of businesses – an exciting prospect that will support the health of millions.”

As well as pain-free, at home blood collection, Qured’s offering extends to clinical consultations for heart health, weight and metabolism, clinical chronic disease and fatigue. It also offers services for chronic disease and cancer screening for men over 40, and chronic disease, bowel cancer and menopause screening for women over 40.

Founded in 2007, Epassi is a leading provider of employee benefits technology, operating across Finland, Sweden, Germany, the Netherlands, Italy, the UK and Ireland. Epassi’s innovative, mobile and digital first platform serves around 43,000 employers and their more than 22 million employees. Its partnership with Qured will add to the business’ 97,000 service providers across its benefits ecosystem.

About Epassi UK
Epassi UK is the UK’s leading benefits and wellbeing hub supporting over 11 million employees. It recently acquired employee benefits platform, Zest and is part of the wider Epassi Group.

Founded in 2007, Epassi Group is a leading provider of employee benefits technology operating across Finland, Sweden, Germany, the Netherlands, Italy, the UK and Ireland. Epassi’s innovative, mobile and digital first platform serves over 50,000 employers across Europe and their 36 million employees. Epassi Group partners with over 107,000 service providers across Europe.

Epassi has been recognised by the Financial Times as one of the fastest growing companies in Europe in 2022, 2023, 2024, and 2025, also featuring on its “Europe’s Long-term Growth Champions 2025” list.

https://epassi.co.uk/en/

About Qured

Qured is a UK leader in preventative healthcare, delivering innovative screening and clinical support to enhance the wellbeing of tens of thousands of public and private sector employees. Qured’s technology empowers individuals to take control of their health - providing pain-free home testing, personalised insights, GP consultations and rapid onward referrals. Qured’s services are trusted by major employers, including Network Rail and Bechtle to reduce absence, improve long-term health outcomes and unlock employee health data. With a proven 4-6x business ROI, Qured is redefining workplace health as a strategic investment.